Physician profile
Robert C Andersen
NPI 1043446131
$1,256.08
in general payments reported to CMS, 2019-2025
11 companies · $33.48 in 2025
The $33.48 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2021: $808 · 2022: $32.16 · 2023: $126 · 2024: $108 · 2025: $33.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $658.13 | 2021 | |
| Abbott Laboratories | $164.88 | 2021-2022 | |
| Smith+Nephew, INC. | $125.84 | 2023 | Oasis, Stravix Pl, Grafix |
| Nevro Corp. | $98.08 | 2024 | Senza |
| Medtronic Vascular, INC. | $84.69 | 2019 | |
| Trilliant Surgical LLC. | $44.88 | 2019 | |
| Advanced Oxygen Therapy INC. | $28.21 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Stryker Corporation | $18.67 | 2019 | |
| Surgenex LLC | $15.51 | 2025 | Ardeograft, Surmatrix, Pellograft |
| Bioventus LLC | $12.12 | 2022 | |
| Orthofix Medical, INC. | $5.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.